Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Lancet (London, England)
|
October 26, 1999
Differences in lung bioavailability between different propellants for fluticasone propionate
A M Wilson, E J Sims, L C Orr, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
February 13, 2001
Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis
A M Wilson, L C Orr, E J Sims, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 13, 2000
Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma
A M Wilson, L C Orr, E J Sims, et al.
British Journal of Clinical Pharmacology
|
July 17, 2001
Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate
S J Fowler, L C Orr, A M Wilson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
May 11, 2002
A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis
A M Wilson, L C Orr, W J R Coutie, et al.
Thorax
|
September 27, 2002
Airway and systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with asthma
G P Currie, S J Fowler, A M Wilson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
November 1, 2001
Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis
A M Wilson, E J Sims, L C Orr, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Lancet (London, England)
|
October 26, 1999
Differences in lung bioavailability between different propellants for fluticasone propionate
A M Wilson, E J Sims, L C Orr, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
February 13, 2001
Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis
A M Wilson, L C Orr, E J Sims, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 13, 2000
Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma
A M Wilson, L C Orr, E J Sims, et al.
British Journal of Clinical Pharmacology
|
July 17, 2001
Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate
S J Fowler, L C Orr, A M Wilson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
May 11, 2002
A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis
A M Wilson, L C Orr, W J R Coutie, et al.
Thorax
|
September 27, 2002
Airway and systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with asthma
G P Currie, S J Fowler, A M Wilson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
November 1, 2001
Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis
A M Wilson, E J Sims, L C Orr, et al.
Page
of 1